Document Type
Article
Publication Date
6-12-2023
Original Citation
Siddiqa A,
Wang Y,
Thapa M,
Martin D,
Cadar A,
Bartley J,
Li S.
A pilot metabolomic study of drug interaction with the immune response to seasonal influenza vaccination. NPJ Vaccines. 2023;8(1):92.
Keywords
JGM
JAX Source
NPJ Vaccines. 2023;8(1):92.
ISSN
2059-0105
PMID
37308481
DOI
https://doi.org/10.1038/s41541-023-00682-2
Grant
This research was conducted while JMB was Diamond/American Federation for Aging Research (AFAR) award recipient. This work was in parted funded by NIH grants NCI U01 CA235493 (SL), NIAID R01 AI149746 (SL), NIA P30AG067988 (SL and JMB, the UConn Claude D. Pepper Older Americans Independence Center). ANC was supported by a NIAMS/NIH predoctoral fellowship (T32AR079114).
Abstract
Many human diseases, including metabolic diseases, are intertwined with the immune system. The understanding of how the human immune system interacts with pharmaceutical drugs is still limited, and epidemiological studies only start to emerge. As the metabolomics technology matures, both drug metabolites and biological responses can be measured in the same global profiling data. Therefore, a new opportunity presents itself to study the interactions between pharmaceutical drugs and immune system in the high-resolution mass spectrometry data. We report here a double-blinded pilot study of seasonal influenza vaccination, where half of the participants received daily metformin administration. Global metabolomics was measured in the plasma samples at six timepoints. Metformin signatures were successfully identified in the metabolomics data. Statistically significant metabolite features were found both for the vaccination effect and for the drug-vaccine interactions. This study demonstrates the concept of using metabolomics to investigate drug interaction with the immune response in human samples directly at molecular levels.
Comments
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http:// creativecommons.org/licenses/by/4.0/.